No needles
No injection training, no sharps disposal, and no weekly appointment with yourself to dread.
FDA-approved · Daily tablet
Wegovy® pill
Oral semaglutide · by Novo Nordisk
Wegovy® pill brings GLP-1 care into a simpler daily routine — the same semaglutide molecule as the pen, in a tablet you take each morning. No needles, no injection training, no refrigeration.
- FDA-approved for chronic weight management in adults with obesity, or overweight plus a weight-related condition
- One tablet each morning, taken on an empty stomach with plain water
- Real, brand-name Wegovy® dispensed through licensed pharmacy partners
- Prescribed only after review by a licensed provider
- Transparent self-pay pricing — shipped directly to your door
Prescription medication. Use alongside a reduced-calorie eating pattern and increased physical activity. Individual results vary.
1 / 4
Daily routine
One pill, taken in the morning
A single small tablet replaces the weekly injection routine.
- Type
- Oral GLP-1 tablet
- Frequency
- Once daily
- Status
- FDA-approved
- Manufacturer
- Novo Nordisk
- Active ingredient
- Semaglutide
Why the pill
Less friction. More routine.
For many people the barrier to GLP-1 care is not the medicine — it is the injection. The tablet removes that step entirely.
Fits the morning
One tablet with water when you wake up, before coffee and breakfast — a habit that anchors easily.
Travels simply
No refrigeration and no cold-pack logistics, so travel and long days do not interrupt treatment.
At a glance
Wegovy® pill at a glance
An FDA-approved GLP-1 for weight management, delivered as daily oral semaglutide.
Mechanism
How oral semaglutide works
Semaglutide mimics GLP-1, a hormone your gut releases after eating that helps regulate hunger and fullness.
Four steps, once a day
The pathway is the same one behind injectable semaglutide — only the delivery route changes.
Take one pill by mouth daily. Morning, empty stomach, plain water.
Semaglutide mimics GLP-1. It activates the same receptors involved in appetite signalling.
Digestion slows and appetite settles. Food leaves the stomach more gradually, so fullness lasts longer.
Weight loss is supported. Alongside reduced-calorie eating and increased activity.
Not a substitute for diet and exercise changes, which remain part of the approved use.
Clinical evidence
Clinically proven for weight loss
One trial. One figure. Reported the way Novo Nordisk reports it.
16.6%
average weight loss at 64 weeks among patients who completed treatment as prescribed.*
13.6%
average weight loss across the overall trial population, including participants who did not fully adhere.*
*Based on the OASIS 4 clinical trial (Novo Nordisk), reflecting participants with obesity or overweight plus a weight-related condition, taken alongside diet and exercise, among those who adhered to treatment through 64 weeks. Individual results vary. Wegovy® is a daily prescription medication used in addition to a reduced-calorie eating pattern and increased physical activity.
Appetite regulation
Feel fuller, longer
Most people describe the change less as willpower and more as quiet — food simply takes up less mental space.
Dosing
How to take it correctly
Oral semaglutide absorption depends on timing. These four steps matter as much as the dose itself.
Morning, empty stomach
Take your tablet when you first wake up, before eating or drinking anything else.
Plain water only
Swallow it whole with no more than about 4 ounces (half a cup) of plain water. No coffee, juice, or other liquids.
Wait 30 minutes
Do not eat, drink, or take other oral medications for at least 30 minutes afterward.
Same time each day
Consistency supports steady levels. If you miss a dose, skip it and take the next one at your usual time — never double up.
Pill vs. pen
Same molecule, two different routines
Both formats deliver semaglutide. The right one is the one you will actually take consistently.
Wegovy® pill — once daily, no needles, no refrigeration, but requires an empty stomach and a 30-minute waiting window every morning.
Wegovy® pen — once weekly, no daily timing rules or food restrictions, but involves a self-administered injection and cold storage.
Provider-guided — your clinician weighs your routine, GI history, other medications, and goals before recommending a format.
Switchable — if one format does not fit your life, your provider can reassess at a follow-up rather than leaving you stuck.
Provider-guided
A short checklist before your first tablet.
Your provider reviews your BMI and weight-related conditions, personal and family thyroid history, pancreatitis and gallbladder history, kidney function, current medications and their absorption timing, pregnancy plans, and what a realistic first 12 weeks looks like for you.
The process
Your treatment journey
From assessment to refills, everything happens online with a licensed provider.
- 01Step 1
Complete a private assessment
Health history, goals, and current medications — about 10 minutes.
- 02Step 2
Provider review
A licensed clinician confirms whether oral semaglutide is appropriate and safe for you.
- 03Step 3
Prescription and delivery
If approved, your brand-name medication ships discreetly to your door.
- 04Step 4
Titration and check-ins
Doses increase gradually with provider guidance to limit GI side effects.
- 05Step 5
Ongoing support
Message your care team about side effects, plateaus, or dosing questions any time.
Common side effects
Nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, fatigue, and headache — most common during dose increases.
Serious risks
Pancreatitis, gallbladder problems, kidney injury from dehydration, worsening diabetic retinopathy, low blood sugar (especially with insulin or sulfonylureas), and serious allergic reactions.
Do not use if
You are pregnant, trying to become pregnant, or breastfeeding, or you have had a serious allergic reaction to semaglutide.
Tell your provider about
Pancreatitis, gallbladder disease, kidney or liver disease, diabetes and its treatments, diabetic eye disease, and every medication you take — oral absorption timing can be affected.
Seek care urgently for
Severe or persistent abdominal pain radiating to the back, ongoing vomiting with signs of dehydration, or symptoms of a severe allergic reaction.
Questions
Wegovy® pill FAQ
Both contain semaglutide, the same GLP-1 receptor agonist. The difference is delivery: the pen is a weekly injection, while the pill is an oral tablet taken once daily. Dosing schedules and absorption requirements differ, so your provider will decide which format suits you.
Take one tablet in the morning on an empty stomach with no more than about 4 ounces of plain water, then wait at least 30 minutes before any other food, drink, or oral medication. Absorption drops sharply if this window is not followed.
In the OASIS 4 clinical trial (Novo Nordisk), participants who adhered to treatment through 64 weeks lost an average of 16.6% of body weight alongside diet and exercise changes; across the broader trial population the average was 13.6%. Individual results vary.
Yes. Wegovy® is approved as an addition to a reduced-calorie eating pattern and increased physical activity, not as a replacement for them. Your care team helps you build a plan you can sustain.
Nausea, vomiting, diarrhea, constipation, abdominal pain, and fatigue are the most frequently reported. They are usually most noticeable during dose increases and often ease with time, hydration, and smaller meals.
Do not take semaglutide if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious allergic reaction to semaglutide. Tell your provider about pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, or pregnancy plans.
No. Graceland Wellness is fully cash-pay with transparent self-pay pricing, and your medication is shipped directly to your door through our licensed pharmacy partners.
Your provider can discuss other options, including the Wegovy® pen, Zepbound®, or Foundayo™ where clinically appropriate.
Also available
Other weight-management options
All of the options below are FDA-approved products prescribed by a licensed provider when clinically appropriate.
Weekly injectionFDA-approved
Wegovy® pen
The same semaglutide molecule in a once-weekly injection with no daily timing rules.
Learn MoreWeekly injectionFDA-approved
Zepbound®
Tirzepatide, a dual GIP/GLP-1 receptor agonist approved for chronic weight management.
Learn More
Get started
Weight-loss care should feel supportive, not overwhelming.
Take a private assessment and a licensed provider will tell you whether the Wegovy® pill — or another option — fits your history, routine, and goals.
Prescription required. Wegovy® is a registered trademark of Novo Nordisk A/S. Graceland Wellness is not affiliated with Novo Nordisk. Transparent self-pay pricing; medication ships directly to your door.